: Recombinant Factor VIII, Plasma-Derived Factor VIII, Extended Half-life Factor VIII, Desmopressin Adjuncts : Hemophilia A Treatment, Surgery Support, Genetic Deficiency Therapy, Prophylaxis Therapy : North America, Europe, Asia-Pacific, South America, Middle East & Africa : CSL Vifor, Octapharma, Grifols, BPL Plasma, LFB, Kedrion Biopharma, Bio Products Laboratory Limited, TAKEDA PHARMACEUTICALS AMERICA, INC., Sanofi, KAMADA, Green Cross Health, Octapharma Plasma, Inc., Baxalta, Catalyst Biosciences, Inhibrx Biosciences, Inc., Rigel Pharmaceuticals Inc., Aptevo Therapeutics Inc, Admac Oncology- Dedicated Oncology Facility, Thermo Fisher Scientific, Emergent BioSolutions, argenx, CSL, Fusion Pharmaceuticals, Medexus Pharmaceuticals, Sartorius, ProteinSimple, a Bio-Techne brand, Biotest AG, Viatris, Mallinckrodt Pharmaceuticals, HEMA Biologics, Catalent Pharma Solutions Brasil, Recipharm, Lonza, Zymeworks Inc., Alvotech, Arcturus Therapeutics, BioMarin Pharmaceutical Inc., Fresenius Kabi, West Pharmaceutical Services #humanfactorviii #pharmaceuticalresearch #hemophiliatherapy #recombinantdrugs #plasmaderivedproteins #biosimilarbiotech #blooddisorders #drugdevelopment #clinicalinnovation To view or add a comment, sign in More from this author Explore related topics Explore content categories

These injections administer antioxidants directly into the bloodstream to reveal the original texture and firmness of the skin
Discussion In this nationwide register study, we investigated the association between new users of GLP-1 RAs, SGLT-2 inhibitor users and DPP-4 inhibitor users and the risk of suicide or suicide attempts
Exerc Sport Sci Rev 49(2):99106 Zanko A, Pawlowski M, Milewski R (2025) The impact of physical exercise on male fertility through its association with various processes and aspects of human biology